Both in Biotechnology
Cabaletta Bio vs Lexeo Therapeutics
Over the past year CABA returned −47.4% and LXEO returned −61.3%; their daily moves had a correlation of 0.37.
CABA −47.4% LXEO −61.3%Growth of $1, one year, split-adjusted
| Metric | CABA | LXEO |
|---|---|---|
| Price | $1.42 | $3.23 |
| Market cap | $240.8M | $265.1M |
| Today | 0.00% | +3.86% |
| 1 month | −29.7% | −2.1% |
| 6 months | −61.9% | −48.2% |
| Year to date | −35.2% | −67.5% |
| 1 year | −52.8% | −64.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $205.1M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 78.7% | 69.2% |
| Short % of float | 27.4% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).